Elmiron (pentosan polysulfate sodium) May Cause Eye Damage To Infants Fed Breastmilk From Mothers Suffering From Interstitial Cystitis (IC)

IC often occurs immediately after childbirth when the mother is breastfeeding

Thursday, February 3, 2022 - Young mothers who are concerned that using Elmiron may cause eyesight damage now have a more significant side effect to worry about. Janssen Pharmaceuticals recently updated the Elmiron (pentosan polysulfate sodium) product websites to include an inference that mothers with interstitial cystitis (IC) should decide to take Elmiron or breastfeed but should not do both. The company has not informed their customers of any research they may be privy to about Elmiron passing through to the baby through breastfeeding, but it seems logical that it could. If that is the case, millions of infants may have been exposed to toxic levels or Elmiron and develop eyesight damage as adults. OrthoElmiron now warns that a mother with IC should decide to treat their bladder pain and feed their child infant formula or to breastfeed and look to alternative ways to treat their chronic bladder pain. "Tell your healthcare provider if you are breastfeeding or plan to breastfeed. It is unknown if Elmiron passes into your breastmilk. You and your healthcare provider should decide if you will take Elmiron or breastfeed." Elmiron has no competition and is routinely prescribed by urologists to patients diagnosed with interstitial cystitis (IC) severe, chronic bladder pain that usually occurs immediately after childbirth. Elmiron eye damage lawyers are representing women and mothers who have taken the drug without warning.

There are currently about 750 Elmiron eye problem, personal injury and wrongful death lawsuits registered in multidistrict litigation formed in U.S. District Court for New Jersey presided over by Judge Brian Martinotti. Hundreds more filed in state courts around the country. A typical Elmiron plaintiff was unaware that the medication prescribed to them could cause them permanent, irreversible blindness that would alter the course of their lives. A typical plaintiff Elmiron eye damage lawsuit seeks about $10 million like the one filed the other day by attorneys for Beverly Frizzell, a New Hampshire woman who suffered retinal damage from the long-term use of Elmiron prescribed to treat her bladder pain. Elmiron eye damage lawsuits allege that Janssen Pharmaceuticals and their parent company Johnson & Johnson failed to warn them of the insidious side effects of taking the drug regularly for many years. Women that have IC also suffer from having to urinate more frequently than is normal, typically up to 20 times per day. Elmiron has been effective in treating both the pain and urinary incontinence of women with IC but takes more than 3 months to build up in the bloodstream before becoming effective. Many women have exceeded the dosage recommendations for taking Elmiron incorrectly thinking that the more they took the quicker and more complete would be the drug's effectiveness. Researchers now believe that Elmiron eye damage is greater the higher the dosage one takes and the longer it is used. Janssen updated their Elmiron warning on their website www.OrthoElmiron.com, to include making sure that one should strictly conform to the product's dosage instructions.

More Recent Elmiron Eye Lawsuit News:

Lawyers for Elmiron Eye Lawsuits

Attorneys handling Elmiron Eye lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Elmiron Eye lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Elmiron Eye lawsuit. The product liability litigators handling Roundup claims at OnderLaw have a strong track record of success in representing families harmed by dangerous drugs and consumer products.